Despite the emergence of newer agents like sodium-glucose cotransporter-2 (SGLT2) inhibitors and GLP-1 receptor agonists, DPP-4 inhibitors have a significant role in diabetes management [1]. The gene discussed is DPP4; the disease is diabetes mellitus.